Galectin Therapeutics News

Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update

May 15 20:00

Galectin Therapeutics | 10-Q: Quarterly report

May 15 19:55

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Zordani Richard A. Jr.

May 1 02:16

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEWIS JOEL

Apr 26 01:30

Galectin Therapeutics | 5: Annual statement of changes in beneficial ownership of securities-10% Owner CZIRR JAMES C

Apr 25 23:40

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner CZIRR JAMES C

Apr 25 23:40

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D

Apr 23 04:08

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D

Apr 10 04:46

Galectin Therapeutics | 8-K: Current report

Mar 29 19:56

Galectin Therapeutics | 10-K: Annual report

Mar 29 19:56

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEWIS JOEL

Mar 5 01:55

Galectin Therapeutics | 3: Initial statement of beneficial ownership of securities-Director CARSON BENJAMIN SR

Feb 16 21:51

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Zordani Richard A. Jr.

Feb 8 05:58

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Uihlein Richard E

Feb 8 05:57

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Schwartz Elissa J.

Feb 8 05:57

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEWIS JOEL

Feb 8 05:53

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director OMENN GILBERT S

Feb 8 05:53

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rubin Marc

Feb 8 05:52

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D

Feb 8 05:52

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CARSON BENJAMIN SR

Feb 8 05:47